MedPath

Clinical study on efficacy and safety of autologous gamma/delta T cell transfer therapy after pulmonary metastasectomy of colorectal cancer

Not Applicable
Conditions
lung metastasis of colorectal cancer
Registration Number
JPRN-UMIN000000854
Lead Sponsor
niversity of Tokyo, Graduate School of Medicine
Brief Summary

Cytotherapy. 2013 Apr;15(4):481-91

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who have - Pulmonary fibrosis or interstitial pneumonia, or their history, or predisposition to them; - Active enteritis, autoimmune diseases, and/or infections - Double cancer; - Other serious complications; - Continuous systemic administration of steroids.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Relapse rate(1 and 2 years)
Secondary Outcome Measures
NameTimeMethod
Relapse free survival Overall survival Survival rate(1 and 2 years) Response of tumor-related markers Immunological response Safety
© Copyright 2025. All Rights Reserved by MedPath